Product image of Irbesartan Medley (Irbesartan) supplied by GNH India

Irbesartan Medley

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartan Medley (Irbesartan)

Irbesartan, the active ingredient in Irbesartan Medley, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It works by selectively blocking AT1 receptors, leading to vasodilation and reduced aldosterone secretion, thereby lowering blood pressure and offering renal protection in patients with hypertension and diabetic kidney disease.

GNH India supplies Irbesartan Medley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with European Union pharmaceutical standards and is distributed through regulated channels to ensure quality and safety.

Manufacturer / TM Owner

Medley Pharma Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Irbesartan is used to treat conditions related to the renin‑angiotensin system, primarily hypertension and kidney disease associated with diabetes.
  • Hypertension: Reduces systolic and diastolic blood pressure in patients with essential hypertension.
  • Diabetic nephropathy: Slows progression of kidney damage in type 2 diabetes.
  • Chronic kidney disease associated with diabetes: Provides renal protection and helps preserve glomerular filtration rate.

How It Works

  • Irbesartan selectively antagonizes angiotensin II type 1 (AT1) receptors on vascular smooth muscle and adrenal tissue. By blocking these receptors, it prevents angiotensin II‑mediated vasoconstriction and aldosterone release, resulting in reduced peripheral resistance, lower blood pressure, and decreased sodium‑water retention, which together protect renal function.

Side Effects

Irbesartan may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Dizziness: Light‑headed sensation, especially after standing.
  • Headache: Mild to moderate cranial pain.
  • Fatigue: Generalized tiredness.
  • Hyperkalaemia: Elevated serum potassium levels.

Serious or Rare Side Effects

  • Angioedema: Swelling of face, lips, tongue or airway.
  • Severe hypotension: Marked drop in blood pressure causing faintness.
  • Hepatic injury: Elevated liver enzymes or hepatitis.

Precautions & Warnings

  • When prescribing Irbesartan, several safety considerations are recommended.
  • Blood pressure monitoring: Check regularly to ensure therapeutic target is reached.
  • Renal function assessment: Measure serum creatinine and eGFR before and during therapy.
  • Serum potassium surveillance: Monitor potassium levels, especially when combined with potassium‑sparing agents.
  • Pregnancy contraindication: Avoid use in pregnancy due to fetal toxicity (Category D).
  • Caution in hepatic impairment: Adjust dose or monitor closely in patients with liver disease.
  • Store at room temperature: Keep below 25 °C in original packaging, protect from moisture.

Avoid Interactions

Irbesartan can interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Potassium‑sparing diuretics: May cause dangerous hyperkalaemia.
  • ACE inhibitors or aliskiren: Combined use can lead to excessive renal dysfunction and hypotension.
  • Lithium: Increases lithium concentrations, risking toxicity.
  • NSAIDs: Heighten risk of renal impairment and reduced antihypertensive effect.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: May enhance antihypertensive effect, requiring dose adjustment.
  • CYP2C9 inhibitors (e.g., fluconazole): Can raise irbesartan plasma levels.
  • Rifampin: May lower irbesartan concentrations, reducing efficacy.
  • Other antihypertensives (beta‑blockers, calcium channel blockers): Additive blood pressure lowering, monitor for hypotension.

Frequently Asked Questions

Irbesartan Medley contains the ARB irbesartan, which is prescribed to lower high blood pressure and to protect kidney function in patients with diabetic kidney disease. It is part of standard therapy for essential hypertension and for slowing the progression of diabetic nephropathy.

Irbesartan blocks the angiotensin II type 1 (AT1) receptors on blood vessels and adrenal glands. This inhibition prevents angiotensin II‑induced vasoconstriction and aldosterone release, leading to vessel relaxation, reduced sodium retention, and ultimately lower blood pressure and renal protection.

The appropriate dose of Irbesartan Medley is determined by the prescribing clinician based on the patient’s blood pressure, kidney function, and overall health status. The prescriber will select the strength and frequency that best meet the therapeutic goals.

Irbesartan is classified as pregnancy category D, indicating evidence of fetal risk and it should be avoided in pregnant women. Limited data are available for breastfeeding; therefore, use is generally not recommended unless the benefit outweighs the potential risk.

To order Irbesartan Medley, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Both irbesartan (an ARB) and ACE inhibitors lower blood pressure by interfering with the renin‑angiotensin system. ARBs like irbesartan specifically block AT1 receptors, whereas ACE inhibitors prevent the formation of angiotensin II. ARBs are often chosen when patients experience cough or angioedema with ACE inhibitors.

Irbesartan Medley tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Irbesartan Medley is taken orally, usually as a whole tablet swallowed with water. It can be taken with or without food, and patients should follow the dosing schedule prescribed by their healthcare professional.

The most serious adverse reactions to monitor include angioedema (swelling of the face, lips, tongue, or airway), severe hypotension (dangerously low blood pressure), hyperkalaemia (high potassium levels), and significant deterioration of kidney function. Prompt medical attention is required if any of these occur.

Irbesartan Medley should not be used by individuals who are pregnant, have known hypersensitivity to irbesartan or any component of the formulation, or have severe hepatic impairment. Caution is also advised for patients with advanced renal disease or those taking potassium‑increasing medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT